Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-27 · accession 0001601485-21-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-29 | 2021-12-27+ | ELTX | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.63 | +277.2K | 1.64M | +20% | +$730.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-27 | P | A | 66,907 | $2.55 | 1,428,920 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.55 inclusive. |
| 2 | Common | Common Stock | 2021-12-28 | P | A | 210,337 | $2.66 | 1,639,257 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.75 inclusive. |